A BuiltForAI Property
Drug class profile · refreshed daily from federal data

Lead Chelator

2 molecules in this class, $165312 combined CY2024 Part D spend across 78 claims. Class-level guide below for benefits decision-makers: where the money lives, where the savings live.

Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annualOrange Book: weeklyShortages: daily

Class summary at a glance.

Every drug in the Lead Chelator class tracked across NADAC, Part D Formulary, Part D Spending, FDA Orange Book, and shortage data. Ranked below by CY24 Part D spend. Click any molecule for the full drug profile.

Molecules in class
2tracked in Part D
CY24 Part D spend
$165312combined across class
Total Rx claims
7851 unique beneficiaries
Generic mfrs (active)
0across all molecules

Every drug in this class, ranked by Part D spend.

CY2024 dataCMS Part D Spending Dashboard
01
Succimer
Brand: Chemet · 78 Part D claims (CY24) · 51 beneficiaries · First FDA approval:
Brand-only (no generics) 28 plans require PA
Low NADAC
Avg plan cost
Part D spend $165312  
Class share
100%
of class CY24 spend
View profile →

Related questions.

Q&A librarySourced · reviewed quarterly
pricingWhat is NADAC?pricingIs NADAC the same as my PBM cost?pricingWhat is spread pricing?pricingWhat is a NADAC pass-through PBM contract?pricingWhat's the difference between AWP, MAC, and NADAC?pricingWhat is a dispensing fee in a PBM contract?
Browse all canonical questions →